CluePoints, a provider of risk-based study execution and data quality oversight software for clinical trials, has teamed up with Summit Partners.
The investment by Summit will help CluePoints expand to meet accelerating customer demand worldwide.
CluePointsoffer sponsors and CROs a better way of identifying, visualizing, managing, and documenting trial risks that could compromise patient safety and delay the approval of Investigational Products.
Founded in 1984, Summit Partners is a global alternative investment firm. Summit invests across growth sectors of the economy and has invested in more than 500 companies in healthcare, technology and other growth industries.
Global law firm White & Case has advised Summit Partners LLP on its investment in CluePoints. The team was led by partners Ian Bagshaw and Emmie Jones (both London), and included counsel Thomas Glauden (Brussels), with support from associates Helen Pantelides and Elena Ruggiu (both London) and Philippe Hendrickx and Nick Hallemeesch (both Brussels).
Edited by Ramata Diallo